Chinese patent medicine Liu Wei di Huang Wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: A systematic review of randomized controlled trials

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Wang, Jie ^a   Yao, Kuiwu ^a   Yang, Xiaochen ^a   Liu, Wei ^a   Feng, Bo ^a   Ma, Jizheng ^a   Du, Xinliang ^a   Wang, Pengqian ^b   Xiong, Xingjiang ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b Traditional Chinese Medicine Hospital of Mentougou District   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; CHINESE DRUG; ENALAPRIL; LIU WEI DI HUANG WAN; NIFEDIPINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PRESSURE; DATA BASE; DIASTOLIC BLOOD PRESSURE; DRUG SAFETY; ESSENTIAL HYPERTENSION; HUMAN; PATENT; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 84871431027     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/714805     Document Type: Article

References (25)

1. Sliwa K., Stewart S., Gersh B. J., Hypertension: a global perspective. Circulation 2011 123 24 2892 2896 2-s2.0-79959509371 10.1161/CIRCULATIONAHA.110. 992362
2. Nabel E. G., Cardiovascular disease. New England Journal of Medicine 2003 349 1 60 72 2-s2.0-0037785185 10.1056/NEJMra035098 (Pubitemid 36765105)
3. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T. Jr., Roccella E. J., Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 42 6 1206 1252 2-s2.0-0347423198 10.1161/01.HYP.0000107251.49515.c2 (Pubitemid 37553153)
4. Levy D., Larson M. G., Vasan R. S., Kannel W. B., Ho K. K. L., The progression from hypertension to congestive heart failure. Journal of the American Medical Association 1996 275 20 1557 1562 2-s2.0-0030002580 10.1001/jama.275.20.1557 (Pubitemid 26154241)
5. Chang C., Gershwin M. E., Integrative medicine in allergy and immunology. Clinical Reviews in Allergy and Immunology. In press 10.1007/s12016-012-8314-2
6. Su D., Li L., Trends in the use of complementary and alternative medicine in the United States: 2002-2007. Journal of Health Care for the Poor and Underserved 2011 22 1 296 310 2-s2.0-79951658749
7. Jiang M., Zhang C., Cao H., Chan K., Lu A., The role of Chinese medicine in the treatment of chronic diseases in China. Planta Medica 2011 77 9 873 881 2-s2.0-79958769350 10.1055/s-0030-1270983
8. Xu H., Chen K., Integrative medicine: the experience from China. Journal of Alternative and Complementary Medicine 2008 14 1 3 7 2-s2.0-38749126248 10.1089/acm.2006.6329 (Pubitemid 351185427)
9. Wang J., Xiong X. J., Current situation and perspectives of clinical study in integrative medicine in China. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 268542 10.1155/2012/268542
10. Zhong G. W., Chen M. J., Luo Y. H., Xiang L. L., Xie Q. Y., Li Y. H., Zhang C., Gao F., Effect of Chinese herbal medicine for calming Gan and suppressing hyperactive yang on arterial elasticity function and circadian rhythm of blood pressure in patients with essential hypertension. Chinese Journal of Integrative Medicine 2011 17 6 414 420 2-s2.0-79960134588 10.1007/s11655-011-0761-6
11. Flachskampf F. A., Gallasch J., Gefeller O., Gan J., Mao J., Pfahlberg A. B., Wortmann A., Klinghammer L., Pflederer W., Daniel W. G., Randomized trial of acupuncture to lower blood pressure. Circulation 2007 115 24 3121 3129 2-s2.0-34250695966 10.1161/CIRCULATIONAHA.106.661140 (Pubitemid 46956501)
12. Li H., Liu L. T., Zhao W. M., Liu J. G., Yao M. J., Han Y. X., Shen Y. P., Liu X. D., Liu L., Wang X. M., Cai L. L., Guan J., Effect of traditional and integrative regimens on quality of life and early renal impairment in elderly patients with isolated systolic hypertension. Chinese Journal of Integrative Medicine 2010 16 3 216 221 2-s2.0-78149419835 10.1007/s11655-010-0216-y
13. Lu L., Zhou J. Z., Wang L., Zhang T. X., Effects of Xuezhikang and Pravastatin on circulating endothelial progenitor cells in patients with essential hypertension. Chinese Journal of Integrative Medicine 2009 15 4 266 271 2-s2.0-70350103233 10.1007/s11655-009-0266-x
14. Macklin E. A., Wayne P. M., Kalish L. A., Valaskatgis P., Thompson J., Pian-Smith M. C. M., Zhang Q., Stevens S., Goertz C., Prineas R. J., Buczynski B., Zusman R. M., Stop Hypertension with the Acupuncture Research Program (SHARP): results of a randomized, controlled clinical trial. Hypertension 2006 48 5 838 845 2-s2.0-33750257495 10.1161/01.HYP.0000241090.28070.4c (Pubitemid 44610995)
15. Zhang T. D., Li C. X., Protective effeets of liuwei dihuang wan on the kidney of patients with senile hypertension. Shi Jie Ke Xue Ji Shu: Zhong Yi Yao Xian Dai Hua 2006 8 2 102 104
16. Wu S. X., Lin X. S., Clinical effect of liuwei dihuang wan on the level of vWF in patients with hypertension. Fujian Zhong Yi Yao 2000 31 6 5 6
17. Wang J., Xiong X. J., Control strategy on hypertension in Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 284847 10.1155/2012/284847
18. Cai L. H., Clinical effect of Liu Wei Di Huang Wan on ET and NO in patients with senile hypertension. Zhong Yi Yao Xue Kan 2004 22 7 1280 1281
19. 2-MG in patients with essential hypertension. Gansu Zhong Yi 2007 20 9 54 55
20. Chen G. Q., Lai W. Y., Chen K., Xu X. J., Clinical study on the therapy of elder essential hypertension using liu wei di huang pill and captopril. Hannan Yi Xue Yuan Xue Bao 2008 14 4 357 358
21. Zhang N., Liu L., Jin J., Clinical study on essential hypertension treated by the therapy of combination of traditional Chinese medicine and western medicine. Zhong Yi Yao Xin Xi 2004 21 3 29 30
22. Zhou Y. L., Zhou Z. W., Tang M. X., Clinical study of combination of liu wei di huang pills and basintom for the treatment of essential hypertension. Hunan Zhong Yi Yao Dao Bao 2003 9 11 15 16
23. Hu L. B., Ma H. Y., Yang Z. F., Ren M. F., Clinical immunology of essential hypertension belonged to the types of Yang hyperactivity and Yin deficiency treated by combining Luiwei Rehmannia pill with nifedipine. Xinxiang Yi Xue Yuan Xue Bao 1994 11 1 279 282
24. Higgins J. P. T., Green S., Corchrane Reviewers' Handbook 5. 1. 0 2011 Review Manager
25. Wang J., Wang P. Q., Xiong X. J., Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine. Internal Medicine 2012 2 3, article 113 10.4172/2165-8048.1000113